Taysha Gene Therapies (NASDAQ:TSHA – Get Free Report) and Rani Therapeutics (NASDAQ:RANI – Get Free Report) are both small-cap healthcare companies, but which is the better investment? Get Taysha Gene Therapies alerts:Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Taysha Gene Therapies $7.47 million 252.32 -$109.00 million ($0.38) -17.26 Rani Therapeutics $1.63 million 60.19 -$29.67 million ($0.41) -1.93Volatility & RiskRani Therapeutics has lower revenue, but higher earnings than Taysha Gene Therapies. ProfitabilityThis table compares Taysha Gene Therapies and Rani Therapeutics’ net margins, return on equity and return on assets. Net Margins Return on Equity Return on Assets Taysha Gene Therapies N/A -56.07% -40.16% Rani Therapeutics N/A -206.46% -83.95%Analyst RecommendationsThis is a breakdown of recent recommendations and price targets for Taysha Gene Therapies and Rani Therapeutics, as reported by MarketBeat. Given Rani Therapeutics’ higher probable upside, analysts clearly believe Rani Therapeutics is more favorable than Taysha Gene Therapies.